SCHEMBL6320203

SCHEMBL6320203

O=P(c1ccccc1)(c1ccccc1)c1ccc2c(c1-c1c(P(=O)(c3ccccc3)c3ccccc3)ccc3c1OCCO3)OCCO2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.37
NPC1 O15118 3/20 0.37
ITGB2 P05107 1/20 0.36
ICAM1 P05362 1/20 0.36
ITGAL P20701 1/20 0.36
HPGD P15428 3/20 0.36
NPSR1 Q6W5P4 3/20 0.36
KDM4E B2RXH2 2/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 4/20 0.34
PKM P14618 1/20 0.34
NFKB1 P19838 1/20 0.34
MAOB P27338 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
HTT P42858 3/20 0.33
LMNA P02545 2/20 0.33
CRHBP P24387 2/20 0.33
CRHR2 Q13324 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7592861 0.87 NPC1 (0.37) RAB9ANPC1HPGDNPSR1SMN1; SMN2
SCHEMBL6321843 0.84 NPC1 (0.38) RAB9ANPC1HPGDNPSR1KDM4E
SCHEMBL6319700 0.80 NPC1 (0.35) RAB9ANPC1HPGDKDM4EMEN1
SCHEMBL4847287 0.77 SMN1; SMN2 (0.33) RAB9ANPC1NPSR1KDM4EMEN1
SCHEMBL4846541 0.77 SMN1; SMN2 (0.35) RAB9ANPC1NPSR1KDM4EMEN1
SCHEMBL6321851 0.76 KDM4E (0.36) RAB9ANPC1ITGB2ICAM1ITGAL
SCHEMBL13681624 0.75 GRM5 (0.38) NPSR1KDM4EHTTALDH1A1MAPT
SCHEMBL7164438 0.74 NPSR1 (0.39) RAB9ANPC1ITGB2ICAM1ITGAL
SCHEMBL6329470 0.73 CTNNB1 (0.35) NPSR1MEN1KMT2AHTTALDH1A1
SCHEMBL7593128 0.72 NPC1 (0.35) RAB9ANPC1HPGDNPSR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6878665-B2 Diphosphines, their complexes with transisition metals and their use in asymmetric synthesis SYNKEM (FR) 2005-04-12 US disclosed
US-20040260101-A1 Novel diphosphines, their complexes with transisition metals and their use in asymmetric synthesis SYNKEM (FR) 2004-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040260101-A1 Novel diphosphines, their complexes with transisition metals and their use in asymmetric synthesis TPI1, TCP1, TTI2 RAB9A 119/4885NPC1 1888/4885ITGB2 1336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.